Alleviation of imiquimod-induced psoriasis-like symptoms in Rorα-deficient mouse skinopen access
- Authors
- Park, Koog Chan; Kim, Jiwon; Lee, Aram; Lim, Jong-Seok; Kim, Keun Il
- Issue Date
- May-2023
- Publisher
- 생화학분자생물학회
- Keywords
- Imiquimod; Keratinocytes; Psoriasis; RORα; STAT3
- Citation
- BMB reports, v.56, no.5, pp 296 - 301
- Pages
- 6
- Journal Title
- BMB reports
- Volume
- 56
- Number
- 5
- Start Page
- 296
- End Page
- 301
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/159483
- DOI
- 10.5483/BMBRep.2022-0169
- ISSN
- 1976-6696
1976-670X
- Abstract
- Retinoic acid receptor-related orphan receptor α (RORα) plays a vital role in various physiological processes, including metabolism, cancer, circadian rhythm, cerebellar development, and inflammation. Although RORα is expressed in the skin, its role in skin physiology remains poorly elucidated. Herein, Rorα was expressed in the basal and suprabasal layers of the epidermis; however, keratinocyte-specific Rorα deletion did not impact normal epidermal formation. Under pathophysiological conditions, Rorα-deficient mice exhibited alleviated psoriasis-like symptoms, including relatively intact epidermal stratification, reduced keratinocyte hyperproliferation, and low-level expression of inflammatory cytokines in keratinocytes. Unexpectedly, the splenic population of Th17 cells was significantly lower in keratinocytespecific RORα deficient mice than in the control. Additionally, Rorα-deficiency reduced imiquimod-induced activation of nuclear factor-κB and STAT3 in keratinocytes. Therefore, we expect that RORα inhibitors act on immune cells and keratinocytes to suppress the onset and progression of psoriasis.as an adjuvant for cancer immunotherapy. [BMB Reports 2023; 56(5): 296-301].
- Files in This Item
-
Go to Link
- Appears in
Collections - 이과대학 > 생명시스템학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.